The list of strategically important medicines in Russia will be expanded

The Cabinet of Ministers of the Russian Federation intends to increase the number of positions in the register of strategically important medicines. The corresponding statement was made by the head of government Mikhail Mishustin during the meeting of the Cabinet.

According to the Prime Minister, to date, this list includes 354 medicines. In the near future, we will introduce a number of new names in demand in the treatment of severe pathologies, including diabetes, cancer and acute myocardial infarction.

Mikhail Mishustin also focused on the need to increase the pace of production of pharmaceutical products and its range. This ensures that residents of both megacities and remote villages will receive quality Russian medicines uninterruptedly. Mishustin also recalled the current strategy for the development of the pharmaceutical industry, the purpose of which is to achieve technological independence.

This summer, the government added 149 positions to the list. Then it included, in particular, human albumin, pancreatin, chlorhexidine, tetracycline, antiencephalitic immunoglobulin, as well as a vaccine against bladder neoplasms (BCG), lorazepam.